Journal of Thoracic Oncology · 2018 · 43 citations · 44 references
MedicineMolecular GeneticsOncologyGenomicsMolecular DiagnosticsMolecular OncologyCancer BiomarkersCancer GenomicsCancer Molecular DiagnosticsCirculating Tumor Dna AnalysisClinical GenomicsLung CancerCirculating Cell-free Dna AnalysisCirculating Cell-free Dna MethylationCirculating Tumor Cell Genomic AnalysisCirculating Tumor Dna DetectionCirculating Tumor Dna DynamicsCirculating Tumor Dna SequencingCirculating Tumor Dna Testing
44
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Caicun Zhou, Yi‐Long Wu, Gongyan Chen et al. · The Lancet Oncology · 2011 · 4.1K citations
Medicine, Oncology, Pharmacology +10
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
Alice T. Shaw, Dong‐Wan Kim, Kazuhiko Nakagawa et al. · New England Journal of Medicine · 2013 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +15
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
Tony Mok, Yi‐Long Wu, Myung‐Ju Ahn et al. · New England Journal of Medicine · 2016 · 3.3K citations · Full text
Medicine, Oncology, Pharmacology +16